￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Medical News

Pralsetinib has significant efficacy in the treatment of RET fusion-positive advanced lung cancer

2025-10-19 11:44:20

Check Details
How effective is the approved third-generation ALK inhibitor lorlatinib/lorlatinib? Are there any side effects?

2025-10-19 11:44:20

Check Details
What is the correct usage and dosage of lorlatinib/lorlatinib? What should I pay attention to when taking lorlatinib?

2025-10-19 11:44:20

Check Details
Has pralsetinib been included in medical insurance? How much does a box cost

2025-10-19 11:44:20

Check Details
Lung cancer EGFR 20ins becomes the second targeted drug-mobotinib

2025-10-19 11:44:20

Check Details
Patients in Hubei still don’t know where to buy mobotinib? Look here!

2025-10-19 11:44:20

Check Details
Serpatinib is a highly selective and effective oral drug_Corx

2025-10-19 11:44:20

Check Details
How much does a box of Serpatinib cost? Is serpatinib available in China

2025-10-19 11:44:20

Check Details
What should I pay attention to when using entrectinib? How long will it take for entrectinib to become resistant

2025-10-19 11:44:20

Check Details
What is the efficacy of lorlatinib/lorlatinib for advanced non-small cell lung cancer?

2025-10-19 11:44:20

Check Details
What are the contraindications for lorlatinib/lorlatinib? What are the side effects?

2025-10-19 11:44:20

Check Details
Rybrevant Approved in the U.S. to Treat Lung Cancer with EGFR Exon 20 Insertion Mutations

2025-10-19 11:44:20

Check Details
Category
相关知识